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Treponema pallidum subsp. pallidum, the causative agent of syphilis, is a highly invasive spirochete 
pathogen that uses the vasculature to disseminate throughout the body. Identification of bacterial 
factors promoting dissemination is crucial for syphilis vaccine development. An important step in 
dissemination is bacterial adhesion to blood vessel surfaces, a process mediated by bacterial proteins 
that can withstand forces imposed on adhesive bonds by blood flow (vascular adhesins). The study of T. 
pallidum vascular adhesins is hindered by the uncultivable nature of this pathogen. We overcame these 
limitations by expressing T. pallidum adhesin Tp0751 (pallilysin) in an adhesion-attenuated strain of 
the cultivable spirochete Borrelia burgdorferi. Under fluid shear stress representative of conditions in 
postcapillary venules, Tp0751 restored bacterial-vascular interactions to levels similar to those observed 
for infectious B. burgdorferi and a gain-of-function strain expressing B. burgdorferi vascular adhesin 
BBK32. The strength and stability of Tp0751- and BBK32-dependent endothelial interactions under 
physiological shear stress were similar, although the mechanisms stabilizing these interactions were 
distinct. Tp0751 expression also permitted bacteria to interact with postcapillary venules in live mice 
as effectively as BBK32-expressing strains. These results demonstrate that Tp0751 can function as a 
vascular adhesin.
Treponema pallidum subsp. pallidum is a bacterium from the spirochete family and the causative agent of syphilis. 
Syphilis is a sexually transmitted disease, which is often considered a disease of the past. However, it still repre-
sents a global health problem with 36 million cases and 11 million new infections annually1. Moreover, syphilis 
incidence has increased dramatically over the past two decades in Canada2, the United States3, China4, and in a 
number of European countries5–7. Given its high prevalence, syphilis has a substantial impact on global health. 
Syphilis infection in pregnancy has up to 80% morbidity and can result in stillbirth, neonatal death, and com-
plications associated with congenital syphilis in newborns8. Active syphilis infection also significantly increases 
infectivity of HIV-positive patients and risk of HIV acquisition9, and modeling studies suggest that controlling 
syphilis will contribute to HIV prevention10. Since elimination of syphilis has not been achieved by antibiotic 
treatment, novel preventative approaches are needed to fight this disease.
To date, the molecular mechanisms of T. pallidum pathogenesis are still poorly understood. This is mainly 
because the organism is an obligate human pathogen that cannot be cultured continuously in vitro11. The inability 
to culture T. pallidum has limited the use of many experimental approaches, including genetic manipulation to 
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study the molecular pathogenesis of this bacterium. To overcome this issue, a heterologous gain-of-function 
system for expressing candidate T. pallidum virulence genes in related culturable organisms is needed. The T. 
pallidum protein Tp0751 has been successfully expressed in the culturable non-adherent spirochete Treponema 
phagedenis, where it restores the capacity for host cell adhesion under static conditions12. Recently, expression of 
a candidate T. pallidum protein (Tp0435) in the Lyme disease spirochete Borrelia burgdorferi has been used to 
establish its role in immune evasion and host cell adhesion13.
T. pallidum disseminates widely via the bloodstream to invade multiple tissues and organs and the interaction 
of T. pallidum with the vasculature is therefore a critical step of the infection process14. Dissemination allows the 
pathogen to spread from the initial site of infection to secondary target tissues including, but not limited to, the 
oral cavity15, kidney16, stomach17, spleen18, liver18, and central nervous system19. T. pallidum disseminates not 
only widely, but rapidly; T. pallidum can penetrate endothelial intracellular junctions20–23, and in a rabbit model 
enters the circulatory system within minutes of initial infection24. It also is one of the few pathogens able to cross 
both the blood-brain and placental barriers11, 19, 25. Identification of the mechanisms underlying the extraordinary 
invasiveness of this pathogen is a key to understanding and preventing disease progression.
In order to invade tissue barriers such as the endothelial lining of blood vessels, bacteria must first attach 
to host ligands associated with endothelial surfaces via bacterial adhesion proteins (adhesins)26. These interac-
tions permit bacteria circulating at the speed of blood flow to slow down and transmigrate through the endothe-
lial lining of blood vessels (extravasation). Interaction of circulating bacteria with endothelia and its associated 
extracellular matrix (ECM) is challenging under vascular shear stress conditions. The first step of this process, 
in which surface molecules on blood-borne bacteria interact with molecules on endothelial surfaces, is espe-
cially critical, since binding interactions must be sufficiently strong and stable to withstand the fluid shear stress 
(force) generated by blood flow over vessel walls. Circulating host cells such as leukocytes, for example, must 
slow and roll along endothelial surfaces before they can extravasate. Even in the vessels where shear stress is typ-
ically lowest (postcapillary venules: PCVs), leukocytes require specialized adhesion molecules with catch bond 
properties (bonds which strengthen as force increases) and/or elastic, bungee cord-like tethers, which anchor 
leukocytes to endothelial surfaces to stabilize interactions27. In the absence of such stabilizing mechanisms, 
leukocyte-endothelial interactions are very vulnerable to small changes in force, and leukocytes dissociate from 
endothelia at exponentially faster rates with small, linear increases in shear stress28.
Disseminating bacteria also require specialized adhesins and interaction mechanisms that can withstand the 
forces generated by blood flow, since such mechanisms are necessary for bacteria to slow down and extravasate 
through the endothelial lining of blood vessels. B. burgdorferi-endothelial interactions mediated by the adhesin 
BBK32 become more stable with increasing force under PCV shear stress conditions and thus exhibit catch bond 
properties, and both BBK32-dependent and BBK32-independent B. burgdorferi-endothelial interactions are 
stabilized by tethers29. BBK32-mediated catch bonds also depend on plasma fibronectin (pFn)30. In addition 
to BBK32, a number of other vascular adhesins have recently been identified in B. burgdorferi (BB0347, and 
decorin-binding proteins DbpA and DbpB)31–33 and in Staphylococcus aureus (von Willebrand factor-binding 
protein, vWbp, and fibronectin-binding protein A, FnBPA)34, 35. All of these adhesins, including BBK32, share the 
property of binding to glycosylated structures and/or extracellular matrix components of blood and endothelial 
cells, including von Willebrand factor and fibronectin (Fn)33, 36–39. Additional bacterial adhesins and virulence 
factors such as the B. burgdorferi adhesin P6640 are also likely to be important for transmigration of bacteria 
through endothelial layers after or during shear stress-resistant adhesion. Adhesion of T. pallidum to endothelial 
surfaces under physiological shear stress conditions has not been studied, and adhesins that are strong and sta-
ble enough to permit vascular interactions during dissemination of this pathogen have not yet been identified. 
Identification of adhesins that promote cardiovascular dissemination of T. pallidum will be important for vaccine 
development to prevent the establishment of disseminated infection.
Several T. pallidum proteins have been identified as candidate adhesins, as determined by binding of recom-
binant proteins to ECM components in vitro41–44. One of these proteins, Tp0751 (pallilysin), has been local-
ized to the T. pallidum surface45 and has been found to bind the host ECM components laminin42, fibrinogen46, 
fibronectin (Fn)47, and collagen47, which are important constituents of blood and endothelia. It has been pre-
dicted that Tp0751 promotes dissemination by attaching to host ECM components and by facilitating T. pallidum 
localization to cell junctions45, 46, 48. The Tp0751 crystal structure revealed that interactions of Tp0751 with ECM 
components are facilitated by its unique lipocalin domain49. A lipocalin domain that shares similar unique attrib-
utes to Tp0751 has been identified in the Neisseria meningitidis adhesin fHbp, which is a key component of the 
Meningococcal B vaccines50. Similar to the fHbp protein, Tp0751 represents a promising vaccine candidate, as 
vaccination with Tp0751 inhibits dissemination of T. pallidum within the rabbit host51.
Due to the propensity for Tp0751 to bind to host cell components found in blood and the vasculature and 
the ability of Tp0751 immunization to inhibit treponemal dissemination, in the present study we investigated 
whether Tp0751 can mediate vascular adhesion under the force conditions found in the vasculature. We heterol-
ogously expressed Tp0751 on the surface of a non-infectious adhesion-attenuated strain of B. burgdorferi, which 
was previously used as a gain-of-function model system to identify BBK32 as a vascular adhesin31, 49. We then 
evaluated whether B. burgdorferi expressing Tp0751 could interact with human endothelia under both static and 
physiological shear stress conditions, characterized the biophysical properties of these interactions (strength and 
stability), and determined if Tp0751 could function as a vascular adhesin in the PCVs of live mice. The meth-
ods we have used to characterize the role of Tp0751 in vascular adhesion provide a powerful new repertoire of 
approaches for studying T. pallidum pathogenesis, and will permit identification of other vascular adhesins and 
the underlying mechanisms of dissemination in this important, under-studied human pathogen.
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Results
Adhesion of Tp0751-expressing B. burgdorferi to human endothelia under static conditions. It 
has been hypothesized that Tp0751 contributes to vascular dissemination of T. pallidum due to the capacity of 
this adhesin to attach to ECM components located in close proximity to the vasculature45–47. To test this hypoth-
esis, we cloned the full length Tp0751 gene fused to a C-terminal 3XFLAG tag into a non-infectious BBK32-
deficient adhesion-attenuated green fluorescent protein (GFP)-expressing strain of B. burgdorferi, resulting in 
Tp0751 localization to the bacterial surface (strain Bb-Tp0751)49. Since virulent T. pallidum readily attaches to 
primary human umbilical vein endothelial cells (HUVEC)22, 23, 52, we then measured the ability of Bb-Tp0751 to 
adhere to monolayers of HUVEC in 12-hour co-incubations in the absence of fluid shear stress (Fig. 1). Under 
these static conditions, bacteria expressing Tp0751 adhered to endothelia significantly more efficiently than the 
adhesion-attenuated parent strain (Fig. 1a; “control”). Tp0751-dependent endothelial adhesion was inhibited by 
pre-incubation of bacteria with plasma fibronectin (pFn; the main source of fibronectin in blood) before addition 
to endothelia, but not by pre-incubation of endothelia with pFn before addition of bacteria (Fig. 1a). This result 
suggests that either Fn already present on endothelia was sufficient to mediate interactions, or that interactions 
may be occurring directly with endothelial surfaces. Tp0751 might therefore mediate attachment to endothelia in 
a specific fashion that may be partially dependent upon the presence of pFn.
Interaction of Tp0751-expressing B. burgdorferi with human endothelia under postcapillary 
venule shear stress conditions. In the circulatory system, fluid shear stress created by blood flow over 
vessel walls has a profound impact on the interactions of circulating cells with vascular surfaces27, 53. We therefore 
investigated whether Tp0751 could support B. burgdorferi interactions with HUVEC monolayers in flow cham-
bers at the typical shear stress encountered in PCVs (1 dyn/cm2), which is the site of most B. burgdorferi-vascular 
interactions54. Interactions were measured by manually counting numbers of bacteria that paused on endothelial 
Figure 1. Interaction of Tp0751-expressing strains with human endothelia under static and shear stress 
conditions. (a) Mean ± SEM numbers of parent and Tp0751-expressing B. burgdorferi (Bb-Tp0751) adhered to 
primary human umbilical vein endothelial cell (HUVEC) monolayers after 12 h of co-incubation under static 
(0 dyn/cm2) conditions (HUVECs + Bb, control). HUVECs+ (Bb + pFn): binding of bacteria pre-incubated 
with plasma fibronectin (pFn) to HUVECs. (HUVECs + pFn) + Bb: binding of bacteria to HUVEC pre-
incubated with pFn. N = 3 independent bacterial and endothelial cultures/strain analyzed in 2 experiments. 
(b) Mean ± SEM bacterial interactions per minute with HUVEC under typical postcapillary venule shear stress 
condition (1 dyn/cm2). Videos of representative flow chamber experiments are presented in Supplementary 
Videos S1–S3. Numbers of bacteria that paused and moved more slowly over endothelia under flow were 
manually counted in time-lapses acquired at 15 frames per second (fps). Strains: Negative control strain: 
BBK32-deficient non-infectious adhesion-attenuated B31-A-derived strain (Parent; GCB706: Supplementary 
Table S1). Positive control strains: Parent expressing B. burgdorferi vascular adhesin BBK32 (Bb-BBK32); 
BBK32-expressing B31-derived infectious strain (Infectious; GCB726: Supplementary Table S1). Bb-Tp0751: 
Parent expressing Tp0751. N = 8 independent cultures per strain analyzed in 3 experiments. Statistics: one-way 
Kruskal-Wallis ANOVA with Dunn’s post-test (a), one-way ANOVA with Holm-Sidak post-test (b). *Indicates 
p < 0.05 vs. parent within incubation condition (a) and vs. parent (b).
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surfaces but moved faster than 100 µm/s (tethered; tethered interactions), and numbers of bacteria which paused 
and moved more slowly than 100 µm/s (dragged; untethered interactions) along endothelial surfaces (Fig. 1b)29, 
31, 54. Interactions were counted for the negative control parent and Bb-Tp0751, as well as parent-derived bacteria 
expressing C-terminally FLAG-tagged BBK32 (positive control: Bb-BBK32). We have previously shown that gain 
of function expression of untagged BBK32 in this parent strain restores PCV interactions to the level observed for 
infectious B. burgdorferi31, 55. It was therefore not surprising that expression of FLAG-tagged BBK32 restored total 
interaction numbers to the same level observed for infectious bacteria (p > 0.05; Fig. 1b). The FLAG tag itself did 
not promote bacterial-endothelial interactions, as addition of the FLAG tag did not affect endothelial interaction 
numbers or velocities at 1 dyn/cm2 for a parent strain expressing RevB (p > 0.05; Supplementary Fig. S1), a B. 
burgdorferi adhesin which does not restore vascular interactions to the adhesion-attenuated parent55. Collectively, 
interaction numbers were similar for Bb-Tp0751 and Bb-BBK32 (p > 0.05; Fig. 1b), and were greater than for the 
parent strain (p < 0.05; Fig. 1b), suggesting that Tp0751 acts as an endothelial adhesin under physiological shear 
stress.
Tp0751 stabilizes and slows B. burgdorferi-endothelial interactions under shear 
stress. Recently, we developed particle-tracking methods for measuring physical properties of B. 
burgdorferi-endothelial interactions under flow, including interaction dissociation rates, velocities, and adhesion 
complex bond strengths29. These methods permit us to determine if specific adhesins stabilize and strengthen 
interactions by slowing bond dissociation (stabilization) and/or increasing the force that load-bearing adhesion 
complexes can sustain (strengthening). Using these approaches, we recently reported that BBK32-dependent 
adhesion complexes have catch bond properties—i.e. become longer-lived with increasing force, and that 
force-dependent catch bond strengthening begins between 0.5 and 1 dyn/cm2, and that BBK32-mediated catch 
bonds are dependent on pFn29, 30. To determine if Tp0751 stabilizes and strengthens endothelial interactions 
under physiological shear stress, we performed flow chamber experiments at 0.5 and 1 dyn/cm2, and measured 
load-bearing bond dissociation rates, velocities and bond forces for interactions captured by particle-tracking 
(Fig. 2). Sample time lapse projections of trajectories obtained by particle tracking are shown in Fig. 2a.
We first determined bond dissociation rates of B. burgdorferi-endothelial interactions for all tracks obtained 
from 0.5–1 dyn/cm2, estimated from the negative slopes of log-transformed frequency distributions of the life-
times of individual interactions (Fig. 2b,c)56. These distributions were linear for all strains (Fig. 2b), indicating 
that each bacterial-endothelial interaction exhibited single molecule dissociation kinetics—i.e. was formed by a 
single load-bearing adhesion complex—or was possibly formed by multiple adhesion complexes which disso-
ciated in a synchronous concerted fashion56. The dissociation rates for Bb-BBK32 and Bb-Tp0751 interactions 
were slower than dissociation rates for the adhesion-attenuated parent (Fig. 2c), indicating that both BBK32 and 
Tp0751 stabilized interactions. Analysis of strain velocities demonstrated that Bb-BBK32 and Bb-Tp0751 also 
moved more slowly over endothelial surfaces than the parent strain (Fig. 2d), indicating that expression of these 
adhesins slowed interactions. Bb-Tp0751 dissociated more slowly but moved faster than Bb-BBK32, implying that 
Tp0751 and BBK32 likely stabilized bacterial-endothelial interactions by different mechanisms. We can conclude 
from these studies that Tp0751 stabilized and slowed B. burgdorferi-endothelial interactions under physiological 
shear stress conditions, but by different mechanisms than BBK32.
Tp0751-dependent stabilization of tethered and untethered endothelial interactions under 
shear stress. The first steps of B. burgdorferi interactions with PCVs are tethering, where bacteria pause 
briefly on endothelial surfaces but travel at >100 µm/s (tethered interactions), and dragging, which occurs when 
bacteria move at <100 µm/s over endothelial surfaces (untethered interactions)29, 31, 54. Tethering B. burgdorferi 
displace further than their cell length under flow, and are anchored to endothelia by tethers analogous to bungee 
cords which stabilize interactions; dragging interactions are untethered, and bacteria displace less than their cell 
length during each adhesion event29. Tethering and dragging interactions are mechanistically distinct29, 55. Since 
tethering exerts a strong stabilizing force on interactions29, 30, understanding how individual adhesins stabilize 
interactions also requires examination of adhesin’s effects on untethered interactions, where interpretation of an 
adhesin’s interaction-stabilizing properties is not confounded by the effects of tethering. BBK32 stabilizes both 
tethering and dragging interactions29, 31, 55. Therefore, we investigated whether Tp0751 also contributed to both of 
these interaction types (Fig. 3).
Bb-BBK32 spent a smaller proportion of the total interaction time tethering compared to the parent strain 
(Fig. 3a), although the lengths of tethers supporting parent and Bb-BBK32 interactions were similar (Fig. 3b). This 
result implied that the Bb-BBK32 strain was likely less reliant on tethering for stabilization of interactions than the 
parent strain. By contrast, parent and Bb-Tp0751 strains spent a similar proportion of the total interaction time 
tethering (Fig. 3a), and tether lengths were longer for Bb-Tp0751 than for both the parent strain and Bb-BBK32 
(Fig. 3b). This result suggested that Bb-Tp0751 was as reliant on tethering for interaction stabilization as the par-
ent strain, but that the tethers associated with Tp0751 adhesion complexes were possibly longer-lived compared 
to the parent strain and Bb-BBK32.
To test these hypotheses, we examined adhesion complex dissociation rates for untethered (dragging) and 
tethered interactions in Bb-Tp0751 and Bb-BBK32 strains (Fig. 3c,d). Untethered Bb-BBK32 interactions dissoci-
ated more slowly than untethered parental interactions (Fig. 3c), demonstrating that BBK32 expression increased 
the stability (lifetime) of untethered interactions. However, untethered Bb-Tp0751 and parental strain interac-
tions dissociated at similar rates, which were comparable to the non-specific dissociation rates of negative control 
beads (Fig. 3c). Thus, BBK32 stabilized untethered interactions, but Tp0751 did not. In contrast, although both 
BBK32 and Tp0751 expression increased the stability of tethered interactions compared to the parental strain, 
tethered Bb-Tp0751 interactions dissociated more slowly than tethered Bb-BBK32 interactions (Fig. 3d). Thus, 
Tp0751 promoted endothelial interactions at physiological shear stress specifically by stabilizing tethering.
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Finally, we examined how Tp0751 expression affected the velocities of untethered and tethered interactions 
(Fig. 3e,f). As expected, based on the rapid dissociation rates of untethered Tp0751-dependent interactions 
(Fig. 3c), Bb-Tp0751 bacteria moved as rapidly as the parent strain over endothelial surfaces, whereas Bb-BBK32 
bacteria moved more slowly than the parent strain (Fig. 3e). The velocities of tethered Bb-Tp0751 and Bb-BBK32 
interactions were slower than the velocity of tethered parental interactions but were similar to each other (Fig. 3f). 
This result implied that tethers extended at a similar speed in both strains, suggesting that tethers were likely 
longer in Tp0751-expressing bacteria (Fig. 3b) because they were longer-lived and thus extended further (Fig. 3d). 
Collectively, these results showed that Tp0751 promoted bacterial association with endothelia under physiologi-
cal shear stress specifically by stabilizing tethered but not untethered interactions.
Tp0751 strengthens B. burgdorferi-endothelial interactions under shear stress. We recently 
found that under physiological shear stress conditions, BBK32 expression increases the strength of B. 
burgdorferi-endothelial interactions, which can be determined by estimating the force imposed on load-bearing 
adhesion complexes (bond force) during interactions29. We also found that BBK32-dependent interactions 
become longer-lived as bond force increases and thus exhibit catch bond properties29. BBK32-dependent 
catch bond properties are most evident for untethered B. burgdorferi interactions, where the force sustained by 
load-bearing bonds is typically greater than for tethered interactions, and is greater than the force threshold at 
which BBK32-dependent catch bond properties are activated (0.2 pN)29.
To determine if Tp0751 strengthened B. burgdorferi-endothelial interactions under shear stress, we esti-
mated the forces sustained by load-bearing adhesion complexes during interactions (Fig. 4). Tp0751 expression 
increased the force sustained by these complexes compared to the parent strain for all interactions (untethered 
Figure 2. Bond dissociation rates and interaction velocities of Tp0751-expressing B. burgdorferi. B. burgdorferi 
interactions with HUVEC in flow chambers at 0.5 and 1 dyn/cm2 were captured by particle tracking of 
interaction trajectories (tracks) in time lapse sequences. (a) Sample time lapse projections depicting interaction 
tracks of individual bacteria (1 color/bacterium) captured at 1 dyn/cm2 over 2 min. Scale bars: 38 µm. (b) 
The linear regression of the log-transformed number of interactions versus the lifetime (seconds) of the 
spirochete for 4 representative tracks (1 track for each of the 4 strains). The negative slope of each regression 
was an estimate of the dissociation rate (Koff) of the spirochete, as described in the Materials and Methods. 
(c) Mean ± SEM dissociation rates (Koff/off-rates) for individual load-bearing adhesion complexes mediating 
bacterial-endothelial interactions under flow. (d) Velocities of interacting bacteria (mean ± 95% CI). In 
(b–d), bond dissociation rates and interaction velocities were calculated from interactions obtained at both 
0.5 and 1 dyn/cm2. N = 4 and N = 8 independent flow chamber experiments for each strain at 0.5 and 1 dyn/
cm2, respectively. Eight replicate experiments were conducted at 1 dyn/cm2 to obtain sufficient interaction 
numbers for tracking. Strains: Negative control strain: BBK32-deficient non-infectious adhesion-attenuated 
B31-A-derived strain (Parent; GCB706: Supplementary Table S1). Positive control strains: Parent expressing B. 
burgdorferi vascular adhesin BBK32 (Bb-BBK32); BBK32-expressing B31-derived infectious strain (Infectious; 
GCB726: Supplementary Table S1). Bb-Tp0751: Parent expressing Tp0751. Numbers of interactions analyzed/
strain: Parent (408), Infectious (647), Bb-BBK32 (578), and Bb-Tp0751 (288). R2 values for linear regressions in 
(b): >0.9. Statistics: one-way ANOVA with Holm-Sidak post-tests (c), one-way Kruskal-Wallis ANOVA with 
Dunn’s post-tests (d). *Indicates p < 0.05 vs parent. +Indicates p < 0.05 vs Bb-BBK32.
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and tethered combined) (Fig. 4a), as well as untethered (Fig. 4b) and tethered (Fig. 4c) interactions. Average 
Bb-Tp0751 and Bb-BBK32 bond forces for all interactions were similar (p > 0.05; Fig. 4a), as were bond forces for 
Figure 3. Effect of Tp0751 on tethered and untethered interaction stability and velocity under shear stress. 
B. burgdorferi interacts with endothelia under PCV shear stress conditions by two mechanisms: untethered 
(dragging) interactions, and tethered interactions. Tethered interactions are stabilized by bungee cord-like 
tethers which anchor bacteria to endothelia, reduce force imposed on load-bearing adhesion complexes and 
increase adhesion bond stability (lifetime)29. (a,b) Proportion of total bacterial-endothelial interaction times 
during which bacterial length extended beyond the normal length, indicative of tether formation stabilizing 
the interaction ((a) % duration), and the average tether length (b) for all interactions at 0.5–1 dyn/cm2. (c,d) 
Interaction complex dissociation rates for untethered (c) and tethered (d) interactions. Dotted lines indicate 
dissociation rates for non-specific interactions (non-adherent beads). (e,f) Velocities of untethered (e) and 
tethered (f) interactions. Summary values: mean ± 95% CI (a,b,e,f), mean ± SEM (c,d). Interaction properties 
were calculated from interactions obtained at both 0.5 and 1 dyn/cm2. N = 4 and N = 8 independent flow 
chamber experiments for each strain at 0.5 and 1 dyn/cm2, respectively. Strains: Negative control strain: BBK32-
deficient non-infectious adhesion-attenuated B31-A-derived strain (Parent; GCB706: Supplementary Table S1). 
Positive control strains: Parent expressing B. burgdorferi vascular adhesin BBK32 (Bb-BBK32); BBK32-
expressing B31-derived infectious strain (Infectious; GCB726: Supplementary Table S1). Bb-Tp0751: Parent 
expressing Tp0751. Numbers of interactions analyzed/strain (a,b): ≥288; (c,e): parent (42), infectious (127), Bb-
BBK32 (130) and Bb-Tp0751 (39); (d,f): parent (366), infectious (520), Bb-BBK32 (448), and Bb-Tp0751 (249). 
Statistics: one-way Kruskal-Wallis ANOVA with Dunn’s post-tests (a,b,e,f); one-way ANOVA with Holm-Sidak 
post-tests (c,d). *Indicates p < 0.05 vs parent. +Indicates p < 0.05 vs Bb-BBK32.
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Figure 4. Bond strengths of Tp0751-dependent interactions under shear stress. Forces imposed on individual 
load-bearing adhesion bonds (Fb) for bacterial-endothelial interactions tracked at 0.5 and 1 dyn/cm2 were 
estimated as described in the Materials and Methods. (a–c) Bond forces for all (a), untethered (b) and tethered 
(c) interactions (mean ± 95% CI). (d,e) Percentages of tracked interactions for each strain occurring at indicated 
Fb values. Percentages for both tethered and untethered interactions combined are shown in (d), and untethered 
interactions alone are shown in (e). Fb values for all interactions combined were binned by force range to obtain 
Mean ± SEM Fb values plotted on x-axes. For untethered interactions, interactions were grouped by Fb into a 
smaller number of bins than for all interactions combined (e), to provide sufficient interaction numbers in each 
bin for accurate calculation of bond dissociation rates at each bond force (f). For the parent strain and Bb-Tp0751, 
fewer than 25 interactions were obtained in all but the lowest force bin. For these strains, the data from the higher 
force bins were therefore pooled with values from the lowest force bin to obtain sufficient interaction numbers for 
dissociation rate calculations. This resulted in a single data point reflecting the values obtained for all untethered 
interactions for parent and Bb-Tp0751 strains. (f) Effect of increasing bond force on mean ± SEM bond dissociation 
rates. Dotted line indicates the dissociation rate for negative control beads. Strains: Negative control strain: BBK32-
deficient non-infectious adhesion-attenuated B31-A-derived strain (Parent; GCB706: Supplementary Table S1). 
Positive control strains: Parent expressing B. burgdorferi vascular adhesin BBK32 (Bb-BBK32); BBK32-expressing 
B31-derived infectious strain (Infectious; GCB726: Supplementary Table S1). Bb-Tp0751: Parent expressing 
Tp0751. Numbers of interactions analyzed/strain: ≥288 (a,d); ≥39 (b,e,f); ≥249 (c). Statistics: one-way Kruskal-
Wallis ANOVA with Dunn’s post-tests. *Indicates p < 0.05 vs parent. +Indicates p < 0.05 vs BBK32.
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tethered interactions (p > 0.05; Fig. 4c). However, although untethered Bb-Tp0751 interactions sustained greater 
force than the parent, they were substantially weaker than untethered Bb-BBK32 interactions (Fig. 4b). Since 
untethered Bb-Tp0751 interactions were as unstable as untethered parent strain interactions and negative control 
beads (Fig. 3c), these data implied that Tp0751 expression primarily strengthened tethered interactions.
To estimate the range of forces sustained by Tp0751-dependent adhesion complexes, we binned interactions 
by bond force, and examined the proportion of total interactions for each strain within each force bin (Fig. 4d,e). 
For all interaction types combined (untethered and tethered), the proportion of total parent strain interactions 
declined rapidly at bond forces >0.1 pN. In contrast, the percentage of total Bb-Tp0751 and Bb-BBK32 interac-
tions remained stable from >0.1 pN up to ~4 and ~8 pN for Tp0751- and BBK32-expressing bacteria, respec-
tively (Fig. 4d). Therefore, expression of Tp0751 and BBK32 increased the upper range of force which could be 
sustained by load-bearing adhesion complexes by ~40-fold and ~80-fold, respectively.
Untethered BBK32-dependent interactions exhibit catch bond properties above 0.2 pN; in other words, they 
become longer-lived as bond force increases29. To determine if Tp0751 expression conferred catch bond prop-
erties, we examined the proportion of total interactions that were untethered as bond force increased, as well as 
bond dissociation rates (Fig. 4e,f). To obtain sufficient interaction numbers for accurate calculation of dissoci-
ation rates, bins containing fewer than 25 interactions were pooled with lower force bins. For the parent strain 
and Bb-Tp0751, all untethered interactions were pooled into a single bin because so few untethered interactions 
occurred at forces >0.05 pN. The maximum average bond forces that untethered interactions of the parent, 
Bb-Tp0751 and Bb-BBK32 strains could sustain were approximately 0.05, 0.35 and 15 pN, respectively (Fig. 4e). 
Therefore, the force range that untethered Tp0751-dependent interactions could sustain was ~7 times greater 
than the force range for the parent strain, but ~43 times smaller than the force range for the BBK32 strain. Bond 
dissociation rates for untethered Bb-BBK32 interactions slowed as the force increased above ~0.08 pN, which 
is consistent with BBK32 conferring catch bond properties to these interactions (Fig. 4f). However, untethered 
Bb-Tp0751 interactions did not become longer-lived as bond force increased (Fig. 4f), indicating that Tp0751 
expression did not strengthen interactions by a catch bond mechanism. Collectively, these results indicated that 
Tp0751 significantly strengthened B. burgdorferi-endothelial interactions, but over a shorter force range than the 
B. burgdorferi catch bond adhesin BBK32.
Tp0751 promotes interactions with postcapillary venules in vivo. Finally, to determine whether 
Tp0751-dependent adhesion complexes were sufficiently strong to permit vascular adhesion in vivo, we per-
formed intravital microscopy in dermal PCVs of live mice intravenously inoculated with Tp0751-expressing and 
control B. burgdorferi strains (Fig. 5), as previously described31, 54, 55. Since parent and gain-of-function strains 
can be cleared more quickly from the circulation than infectious bacteria55, microscopy was performed only for 
the first 20 min after inoculation to reduce differences among experimental groups due to clearance. As shown 
in Fig. 5a, Tp0751 expression restored vascular interactions to the adhesion-attenuated parent as effectively as 
BBK32 expression, and both Bb-Tp0751 and Bb-BBK32 interacted with PCVs as efficiently as the infectious con-
trol strain (Fig. 5a). To ensure that Tp0751’s ability to promote interactions was not due to protection of bacteria 
from clearance compared to the parent strain, we measured copy number of B. burgdorferi flaB DNA in blood col-
lected from mice immediately after intravital microscopy (IVM) (Fig. 5b), and normalized interaction numbers 
to bacterial copy number (Fig. 5c). B. burgdorferi copy number in blood was not greater in any strain compared 
to the adhesion-attenuated parent strain on the time scale of these experiments (Fig. 5b). Copy number-adjusted 
interaction numbers for all strains were ~6-, 8- and 10-fold greater than parent strain numbers for Bb-Tp0751, 
Bb-BBK32 and infectious bacteria, respectively (Fig. 5c). These results demonstrated that Tp0751 can function as 
a vascular adhesin in vivo.
Figure 5. Interaction of Tp0751-expressing B. burgdorferi with postcapillary venules in vivo. (a) Total 
bacterial interactions per minute with dermal PCVs of live mice, visualized by intravital microscopy (IVM). 
Representative IVM videos are presented in Supplementary Videos S4–S6. Numbers of bacteria that paused 
and moved more slowly over PCV surfaces under flow were manually counted in time-lapses acquired at 15 fps. 
(b) B. burgdorferi flaB DNA copy numbers in blood of mice collected after IVM, as measured by quantitative 
real-time PCR. (c) Copy number-adjusted interactions/min in PCVs. Numbers of mice (venules) analyzed 
per strain: parent: 14 (30); infectious: 8 (22); Bb-BBK32: 8 (24); Bb-Tp0751: 9 (25). Summary values represent 
means ± SEM for experiments performed with ≥4 independent bacterial cultures/strain. Statistics: one-way 
Kruskal-Wallis ANOVA with Dunn’s post-test. *Indicates p < 0.05 vs. parent.
www.nature.com/scientificreports/
9Scientific RepoRts | 7: 1538  | DOI:10.1038/s41598-017-01589-4
Discussion
Like many other invasive pathogens, systemic dissemination via the bloodstream is critical to T. pallidum patho-
genesis. The highly invasive nature of T. pallidum is shown by the widespread rash characteristic of secondary 
syphilis, the ability of the bacterium to cross the placental and blood-brain barriers, and the symptomatic involve-
ment of multiple organs and tissues during the course of infection11, 57. A critical step in bacterial dissemination 
via the bloodstream is attachment to the endothelial lining of blood vessels and associated ECM components. 
Therefore, identifying host-interacting vascular adhesins of T. pallidum is crucial for advancing our understand-
ing of the pathogenic mechanisms of this organism. The fact that T. pallidum is an obligate human pathogen that 
cannot be cultured continuously in vitro11 has hindered progress on understanding the molecular interactions 
involved in the host vasculature-pathogen interface for this organism. Thus, heterologous expression in a related 
spirochete represents an attractive approach for studying the contributions of T. pallidum adhesins to these inter-
actions12, 13.
A gain-of-function approach such as heterologous expression is a powerful genetic tool that has been success-
fully used to identify and analyze adhesion-associated phenotypes conferred by pathogenic spirochetes12, 13, 31, 36, 
55, 58–60. This approach overcomes a major limitation associated with loss-of-function methodologies, where the 
redundancy of multiple adhesins can mask the binding defect of a single adhesin-deficient mutant. By combining 
a heterologous gain-of-function approach with flow-chamber, tracking and biophysical analysis methods, which 
we have recently developed for studying B. burgdorferi-endothelial interaction mechanisms, it is now feasible to 
identify and mechanistically characterize the vascular adhesins supporting T. pallidum dissemination. The ability 
to study this process in flow chambers, which reproduce the interaction phenotypes observed in the complex 
environment of PCVs in live mice (Figs 1 and 5)29, also means that interaction mechanisms can be systematically 
dissected by addition, removal and blocking of host components targeted by bacteria expressing known and 
predicted vascular adhesins. The ability to study bacterial-endothelial interactions in live mice using intravital 
microscopy also provides a powerful method for testing and validating hypotheses generated in flow chamber 
studies. Together, these methods have the potential to rapidly advance our understanding of the mechanisms of 
T. pallidum dissemination.
The results of this study indicate that, like the B. burgdorferi adhesin BBK3229, 31, 55, 59, 61, Tp0751 can function 
as a vascular adhesin under static and flow chamber conditions and in PCVs in mice, although the mechanisms of 
BBK32- and Tp0751-dependent interactions differ (Figs 1, 2, 3, 4 and 5). Tp0751 and BBK32 are multi-functional 
adhesins that bind to several host ECM components including Fn37, 42, 46, 47, 49, 61. Fn plays an important role in B. 
burgdorferi tethering and dragging on vascular surfaces31, with tethering interactions being facilitated by BBK32 
Fn-binding sequences55. Our results suggest that Fn may also be important for Tp0751-dependent endothelial 
interactions (Fig. 1).
Pre-incubation of Tp0751-expressing bacteria (but not endothelia) with pFn inhibited adhesion under static 
conditions (Fig. 1). Therefore, it is possible that differences in Tp0751- and BBK32-dependent interaction prop-
erties under shear stress arise because Tp0751 may target insoluble Fn deposited on endothelial surfaces, whereas 
BBK32-dependent interactions occur via another mechanism. BBK32 binds to Fn by a tandem β-zipper mech-
anism involving extensive regions of both proteins62, 63 and induces Fn polymerization64. By contrast, our recent 
structural studies reveal that Tp0751 interacts with Fn via positively charged residues on only one face of the 
protein’s lipocalin fold49. Thus, even if Fn is a common component of Tp0751- and BBK32-dependent endothelial 
interaction mechanisms, it is likely that the affinity of these proteins for Fn and the conformation and physical 
properties of Fn in adhesion complexes is distinct. Such differences in Fn conformation and/or the mechanisms 
by which Fn is anchored to surfaces and endothelia might account for the smaller range of force that can be sus-
tained by untethered Tp0751 adhesion complexes (Figs 3 and 4).
Structural and peptide mapping studies also reveal that although Tp0751 forms multiple charge-based con-
tacts with Fn and other ECM proteins, Tp0751 adhesion to endothelia may involve distinct residues on the same 
surface of the lipocalin fold as the ECM-coordinating residues49. These observations predict that the initial teth-
ering association of Tp0751-expressing bacteria with endothelial surfaces may be mediated by charge-based 
interactions with ECM components such as Fn, but that subsequent dragging adhesion to endothelial cells likely 
involves a distinct adhesion target. Since untethered dragging interactions were less stable, less abundant and 
weaker for Tp0751-expressing bacteria than for BBK32-expressing counterparts (Figs 3 and 4), the endothelial 
targets for dragging interactions may differ for bacteria expressing these adhesins. Binding of ECM components 
such as Fn to the Tp0751 lipocalin fold may also mask endothelial adhesion sites mediating dragging, suggesting 
that Tp0751 conformational change or detachment from the ECM could be required to expose endothelial inter-
action sites, and/or that dragging interactions might be dependent on a second T. pallidum adhesin which is not 
present in B. burgdorferi.
Despite the work that is still required to fully understand the mechanism of Tp0751-dependent endothe-
lial interactions under physiological shear stress, it is nevertheless clear that Tp0751 can function as a vascular 
adhesin in flow chambers and in dermal PCVs of mice, where shear stress typically ranges from 0.75–1 dyn/cm2 54. 
Our results predict that Tp0751 may be sufficient for bacterial-endothelial interactions in vascular beds of tissues 
such as the skin where PCV shear stress is typically quite low, but that additional, stronger adhesion mechanisms 
are likely required for vascular interactions in organs like the brain, where shear stress is typically considerably 
higher than in the skin. Thus, it is likely that T. pallidum encodes additional adhesins that collectively permit 
pathogen interactions with the vasculature of other dissemination sites in the body.
The model systems and biophysical analysis methodologies described herein have successfully identified 
Tp0751 as a T. pallidum vascular adhesin. Development of these experimental tools represents a powerful advance 
that will enable the identification of additional spirochete vascular adhesins and will increase understanding of 
the molecular mechanisms facilitating vascular attachment of spirochete pathogens, particularly for intractable 
pathogens such as T. pallidum.
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Materials and Methods
Ethics statement. Animal experiments were carried out in accordance with the most recent Guide to the 
Care and Use of Experimental Animals (Canadian Council on Animal Care), and approved by the Animal Care 
Committee of the University of Toronto (protocol 20010430). Work with B. burgdorferi was carried out in accord-
ance with University of Toronto, University of Victoria biosafety permits 12a-M30-2 and 2109-107, respectively, 
and Public Health Agency of Canada and the Canadian Food Inspection Agency guidelines.
Mice, endothelial cells, B. burgdorferi. Four to five-week-old male C57BL/6 mice (Charles River 
Laboratories, Montréal, Canada) were housed at 4 mice/cage, with environmental enrichment and ad libitum 
access to standard chow and water. As described29, experiments were conducted with primary human umbilical 
vein endothelial cells (HUVEC) (Lonza, Allendale, NJ, USA) at passage 2–6. All bacterial strains are listed in the 
Table S1. GFP-expressing B. burgdorferi strains were cultivated in selective medium supplemented with 100 μg/ml 
gentamicin and/or 200 μg/ml kanamycin (Bioshop Canada, Burlington, Canada) as described54. All experiments 
were performed with at least 3 independent cultures/strain. For intravital microscopy experiments, 1% C57BL/6 
mouse blood obtained by cardiac puncture was added to cultures 48 hours before imaging54.
Static adhesion assays. As described12, 65, HUVEC were grown to confluence in 4-well chamber slides 
(Nalgene Nunc International, Rochester, NY, USA) coated with 500 μg/mL phenol red-free matrigel (Corning, 
Tewksbury, MA, USA). GFP-expressing B. burgdorferi (1.4 × 107) were resuspended in a 3:1 mixture of 
BSK-II:EGM-2 and added to duplicate wells containing HUVEC. For competitive inhibition experiments, bac-
teria or HUVEC were pre-incubated with 8 μg of plasma fibronectin (pFn) (Sigma, Oakville, Canada) for 1 hour. 
Chamber slides were incubated for 12 h, washed with HEPES-buffered saline, and fixed in buffered 10% formalin 
(Fisher Scientific, Ottawa, Canada). B. burgdorferi adhered to HUVEC were counted in 10 fields of view/biologi-
cal replicate using a Nikon 80i fluorescence microscope (Meridian Instrument Company, Kent, WA, USA).
Flow chamber assays. Flow chamber assays were performed as described29. Briefly, HUVEC were culti-
vated to 2 days post-confluence in Ibidi µ-Slide VI0.4 flow chambers (Ibidi GmbH, Planegg, Germany), endothe-
lia were labeled with CellMask Deep Red plasma membrane dye (Life Technologies, Burlington, Canada), and 
washed B. burgdorferi diluted to 1 × 108cells/ml in 10% heat-inactivated fetal bovine serum (FBS: Sigma) and 
Hank’s Balanced Salt Solution (HBSS: Life Technologies) were perfused through flow chambers mounted in 
a stage-top live cell imaging incubator (Live Cell Instrument, Seoul, Korea) at 0.5 and 1 dyn/cm2 (0.284 and 
0.568 ml/min, respectively). As reported29, live cell imaging was performed at 14–15 frames/second (fps) using a 
custom-built spinning disk confocal microscope (Quorum Technologies, Guelph, Canada) equipped with a Zeiss 
25×/0.8 NA LCI Plan-Apochromat water immersion lens (Carl Zeiss Canada Ltd., Toronto, Canada) and Volocity 
software v.6.3.0 (Improvision/Perkin-Elmer, Waltham, MA, USA).
Intravital microscopy (IVM). IVM was performed in dorsal flank skin as described55, with the follow-
ing exceptions. Eight hundred µl of bacterial suspension (at 2 × 109/ml in PBS) were mixed with 200 µl of 0.1% 
2 MDa Texas Red Dextran (Life Technologies) and stored on ice. After warming to room temperature, 250 µl 
of this mixture were injected via tail vein in mice anesthetized with 10 mg/kg xylazine (MTC Pharmaceuticals, 
Cambridge, Canada) and 200 mg/kg ketamine hydrochloride (Rogar/STB, Montréal, Canada). Interactions were 
visualized in dermal postcapillary venules (PCVs) for 5–20 min after injection, using a custom-built high speed 
multi-wavelength resonant scanner Leica TCS SP8 confocal microscope (Leica, Mannheim, Germany) equipped 
with argon and DPSS 633 lasers operated at 100% power, a tandem scanner, HCX IRAPO L 25×/0.95 water 
objective, TD 488/561/633 excitation beam splitters and spectral HyD detectors in photon integration mode (100 
gain, 0 offset). Scanning was performed bidirectionally in resonant mode at 8000 Hz over a 1024 × 155 pixel area, 
at 0.227 µm/pixel and 30 fps with line averaging of 3. Pinhole size was 10.74 AU. Emission wavelengths for green 
and red channels were 496–550 and 572–795 nm, respectively, and acquisition in red and green channels was 
simultaneous. Time courses (2 min/PCV) were acquired using Leica Application Suite (LAS) software, and were 
analyzed post-acquisition after import into Volocity software.
After completion of imaging, blood was collected by cardiac puncture, and qPCR measurement of copies of 
B. burgdorferi flaB DNA/µl blood was performed as previously described55. Mice were euthanized after cardiac 
puncture by cervical dislocation.
Analysis of live cell imaging experiments. As described29, 54, B. burgdorferi-endothelial interactions were 
manually counted in 100 µm-long straight unbranched regions of PCVs (10–40 µm diameter) and a 30 × 100 µm 
region of interest (ROI) positioned at the center of flow chamber videos. Interactions were counted as dragging if 
bacteria took >1 s to pass through this ROI, and were counted as tethering if bacteria passed through the ROI in 
<1 s but paused as they travelled.
Semi-automated centroid-based tracking of flow chamber videos was performed using a Volocity, custom 
tracking algorithm as described29. Interactions where bacterial area and velocity were >50 µm2 and 300 µm/s, 
respectively, were excluded from analyses. For all analyses except interaction dissociation rates, each interaction 
was treated as an independent replicate for statistical analysis, since variation in the properties of individual inter-
actions was greater than variation among individual biological replicates29.
Interaction dissociation (Koff) rates were estimated from the negative slopes of linear regressions of 
log-transformed frequency distributions of the duration of individual interactions in populations29, 56. Curve 
fitting was performed by non-linear regression using the least squares method in GraphPad Prism v.6.02 
(GraphPad, La Jolla, CA, USA), with runs post tests. Statistical comparison of the slopes of linear regressions was 
performed by extra-sum-of-squares F-tests. Dissociation rates for non-specific interactions (beads) are provided 
in dissociation rate graphs, as calculated previously29.
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As described29, tracked interactions were classified as tethered or untethered based on (a) the ratio of cumula-
tive displacement to bacterial length measured at each time point of each interaction and (b) tethering duration, 
i.e. the percentage of the total duration of each interaction for which ratios of cumulative displacement to bac-
terial length at each time point were >1. Untethered interactions (dragging) were those where cumulative dis-
placement was less than bacterial length (ratio <1), and 0% of the total interaction duration was spent tethered. 
Tethered interactions (tethering) were those where cumulative displacement was greater than bacterial length 
(ratio >1), and >0% of the total interaction time was spent tethered. Tether length was calculated by dividing the 
average velocity of each interaction by the dissociation rate calculated for the population. This method corrects 
for the effect of acquisition frame rate on tether length measurement29.
As described29, the average force sustained by individual load-bearing adhesion bonds during each interaction 
(Fb) was calculated by averaging instantaneous Fb values obtained at each time point within each interaction29. 
The formula used to estimate instantaneous Fb was Fb = Fs/cosθ, where θ is the bond angle, Fs is the force due to 
flow (31.97τwr2), τw is wall shear stress and r is bacterial projection above the endothelial surface. r was calculated 
from average cell volume values calculated for each bacterial strain as described29. This volume differed among 
strains because of strain-specific differences in average cell length. For experiments reported in this study, aver-
age cell volumes for each strain were calculated from average cell lengths for each strain, which were measured 
under static, no-flow conditions as described29. Average cell lengths for GCB706, GCB726, TMB103 and TMB49 
were16.34, 16.59, 18.09 and 17.99 µm, respectively).
Statistical analysis. All statistical analysis was performed in GraphPad Prism. Statistical tests used for all 
comparisons are described in figure legends and Materials and Methods. Detailed description and justification 
for statistical methods used to analyze all reported biophysical values (Koff, Fb, velocity, tether length, % duration 
tethered) are provided in Ebady et al.29.
Data availability statement. Data underlying the findings reported in this manuscript are included in the 
summarized data presented in the paper and its Supporting Information files. Spreadsheets of raw data can be 
converted and supplied upon requests directed.
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